Compare Ascendis Pharma A/S (ASND) vs Abrdn Physical Platinum Shares ETF (PPLT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ascendis Pharma A/S vs Abrdn Physical Platinum Shares ETF — how do they compare? Ascendis Pharma A/S trades at $253.76 (market cap $16.67B), while Abrdn Physical Platinum Shares ETF trades at $16. The key difference: Ascendis Pharma A/S is trading nearer its 52-week high, Abrdn Physical Platinum Shares ETF nearer its low. Which is the better fit depends on your goals.
| ASND | PPLT | |
|---|---|---|
Market Cap | $16.67B | — |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $277.18 | $25.23 |
52-Week Low | $189.74 | $11.95 |
Enterprise Value | $17.04B | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Ascendis Pharma A/S
Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.
Read more on ASND →About Abrdn Physical Platinum Shares ETF
PPLT is a physically-backed ETF designed to track the spot price of platinum, less the Trust's expenses. It holds physical platinum bullion in secure vaults, providing investors with a liquid and cost-effective way to access the platinum market without the logistical challenges of direct ownership.
Read more on PPLT →
